
IREN Valuation
IREN Ltd
IREN Relative Valuation
IREN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IREN is overvalued; if below, it's undervalued.
Historical Valuation
IREN Ltd (IREN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -40.92. The fair price of IREN Ltd (IREN) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:42.26
Fair
326.33
PE
1Y
3Y
5Y
Trailing
Forward
14.18
EV/EBITDA
IREN Ltd. (IREN) has a current EV/EBITDA of 14.18. The 5-year average EV/EBITDA is 14.91. The thresholds are as follows: Strongly Undervalued below -45.72, Undervalued between -45.72 and -15.41, Fairly Valued between 45.23 and -15.41, Overvalued between 45.23 and 75.55, and Strongly Overvalued above 75.55. The current Forward EV/EBITDA of 14.18 falls within the Historic Trend Line -Fairly Valued range.
55.73
EV/EBIT
IREN Ltd. (IREN) has a current EV/EBIT of 55.73. The 5-year average EV/EBIT is 8.14. The thresholds are as follows: Strongly Undervalued below -47.83, Undervalued between -47.83 and -19.85, Fairly Valued between 36.13 and -19.85, Overvalued between 36.13 and 64.12, and Strongly Overvalued above 64.12. The current Forward EV/EBIT of 55.73 falls within the Overvalued range.
8.33
PS
IREN Ltd. (IREN) has a current PS of 8.33. The 5-year average PS is 3.73. The thresholds are as follows: Strongly Undervalued below -3.51, Undervalued between -3.51 and 0.11, Fairly Valued between 7.35 and 0.11, Overvalued between 7.35 and 10.98, and Strongly Overvalued above 10.98. The current Forward PS of 8.33 falls within the Overvalued range.
6.11
P/OCF
IREN Ltd. (IREN) has a current P/OCF of 6.11. The 5-year average P/OCF is 29.66. The thresholds are as follows: Strongly Undervalued below -163.26, Undervalued between -163.26 and -66.80, Fairly Valued between 126.12 and -66.80, Overvalued between 126.12 and 222.58, and Strongly Overvalued above 222.58. The current Forward P/OCF of 6.11 falls within the Historic Trend Line -Fairly Valued range.
-81.01
P/FCF
IREN Ltd. (IREN) has a current P/FCF of -81.01. The 5-year average P/FCF is -7.74. The thresholds are as follows: Strongly Undervalued below -61.22, Undervalued between -61.22 and -34.48, Fairly Valued between 19.00 and -34.48, Overvalued between 19.00 and 45.74, and Strongly Overvalued above 45.74. The current Forward P/FCF of -81.01 falls within the Strongly Undervalued range.
IREN Ltd (IREN) has a current Price-to-Book (P/B) ratio of 4.16. Compared to its 3-year average P/B ratio of 1.62 , the current P/B ratio is approximately 155.88% higher. Relative to its 5-year average P/B ratio of 1.40, the current P/B ratio is about 197.58% higher. IREN Ltd (IREN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -50.79%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -51.47% , the current FCF yield is about -100.00% lower.
4.16
P/B
Median3y
1.62
Median5y
1.40
-7.12
FCF Yield
Median3y
-50.79
Median5y
-51.47
Competitors Valuation Multiple
The average P/S ratio for IREN's competitors is , providing a benchmark for relative valuation. IREN Ltd Corp (IREN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 355.41%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IREN increased by 212.81% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 52.76M to 240.30M.
The secondary factor is the P/E Change, contributed 120.74%to the performance.
Overall, the performance of IREN in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

CXW
CoreCivic Inc
17.070
USD
+2.15%

AIN
Albany International Corp
45.410
USD
+2.46%

MRCY
Mercury Systems Inc
66.680
USD
+0.85%

KLIC
Kulicke and Soffa Industries Inc
40.880
USD
+4.74%

BANC
Banc of California Inc
17.750
USD
+4.41%

AMRX
Amneal Pharmaceuticals Inc
11.950
USD
+3.78%

SGRY
Surgery Partners Inc
15.840
USD
+3.53%

ODD
Oddity Tech Ltd
37.700
USD
-4.73%

RXRX
Recursion Pharmaceuticals Inc
4.170
USD
+8.31%

ENR
Energizer Holdings Inc
18.270
USD
+3.34%
FAQ
Is IREN Ltd (IREN) currently overvalued or undervalued?
IREN Ltd (IREN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -40.92. The fair price of IREN Ltd (IREN) is between NaN to NaN according to relative valuation methord.









